Lieping Chen, MD, PhD
United Technologies Corporation Professor in Cancer Research and Professor of Immunobiology, of Dermatology and of Medicine (Medical Oncology)
Biography
Research & Publications
News
Locations
Appointments
Biography
Dr. Lieping Chen is an immunologist interested in basic T cell biology, cancer immunology, and translational research to develop new treatments for human diseases including cancer. Prior to joining Yale, he was a faculty member at Johns Hopkins University School of Medicine and Mayo Clinic, and a scientist in Bristol-Myers Squibb Pharmaceutical Research Institute.
Dr. Chen has published over 370 peer-reviewed research articles. His work in the discovery of the PD-1/PD-L1 pathway for cancer immunotherapy was cited as the #1 breakthrough of the year by Science magazine in 2013. He is a member of the National Academy of Sciences and a fellow of the American Association for Cancer Research and the Society for Immunotherapy of Cancer.
Education & Training
- PhDDrexel University, Pathology and Laboratory Medicine (1989)
- MSBeijing Union Medical College, Immunology (1986)
- MDFujian Medical College (1982)
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Richard V. Smalley MD Memorial Award | Society for Immunotherapy of Cancer | 2020 |
| Academician | Academia Sinica | 2018 |
| Giants of Cancer Care | OncLive | 2018 |
| Warren Alpert Foundation Prize | Warren Alpert Foundation | 2017 |
| AAI-Steinman Award | American Association of Immunologists | 2016 |
| William B. Coley Award | Cancer Research Institute | 2014 |
Departments & Organizations
- Cancer Immunology
- Chen Lab
- Human and Translational Immunology Program
- Immunobiology
- Immunology
- Internal Medicine
- K12 Calabresi Immuno-Oncology Training Program (IOTP)
- Medical Oncology
- Rheumatic Diseases Research Core
- Rheumatology, Allergy, & Immunology
- SPORE in Lung Cancer
- Yale Cancer Center
- Yale Combined Program in the Biological and Biomedical Sciences (BBS)
- Yale Ventures